ARCHIVES

CMS, FDA Developing Process For Concurrent Therapy ApprovalsAACI To Honor Mary-Claire King, Sen. Sherrod Brown

This article is from The Cancer Letter archive.

Vol. 36 No. 35 | October 1, 2010

Download PDF Visit The Full Archive

Related Articles

A tissue bank to break the bank? NCI, National Dialogue on Cancer plan expensive resource.

August 8, 2003

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

December 17, 2013

Emory, Children’s Strengthen Ties

May 25, 2001

U.S. Preventive Services Task Force Recommends Mammograms For Over-40.

February 22, 2002